亚龙辉
YHLO assisted in the SARS-CoV-2 serosurveillance research in Madurai, South India
YHLO assisted in the SARS-CoV-2 serosurveillance research in Madurai, South India
YHLO contributes to SARS-CoV-2-specific immune response research in COVID-19 convalescent individuals
YHLO contributes to SARS-CoV-2-specific immune response research in COVID-19 convalescent individuals
YHLO Contributes to Lancet SARS-CoV-2 NAb Research
YHLO Contributes to Lancet SARS-CoV-2 NAb Research
The mixed-and-match vaccine against Covid-19 tested a stronger immune response than two doses of AstraZeneca vaccine.
More
The mixed-and-match vaccine against Covid-19 tested a stronger immune response than two doses of AstraZeneca vaccine.
Previous page
1
Language
Search
亚辉龙

Join Us

关注我们

Wechat

Headquarter: Building 1, YHLO Biopark, Baolong 2nd Road, Baolong Subdistrict, Longgang District, 518116 Shenzhen, P.R.China

Follow YHLO

wechatwechat wechat wechat wechat

© 2020  Shenzhen YHLO Biotech Co., Ltd.  All rights reserved.  粤ICP备19040167号